Nucleic Acids Research, 1987, Vol. 15, No. 22 9195-9214
© 1987
Articles |
Genomic characterization of the human DNA excision repair gene ERCC-1
Department of Cell Biology and Genetics, Erasmus University PO Box 1738, 3000 DR Rotterdam, The Netherlands
Received September 11, 1987. Accepted October 22, 1987.
In this report the genomic characterization of the human excision repair gene ERCC-1 is presented. The gene consists of 10 exons spread over approximately 15 kb. By means of a transfection assay the ERCC-1 promoter was confined to a region of ± 170 bp upstream of the transcriptional start site. Classical promoter elements like CAAT, TATA and GC-boxes are absent from this region. Furthermore, ERCC-1 transcription is not UV-inducible. A possible explanation is provided for the previously reported alternative splicing of exon VIII. Analysis of ERCC-1 cDNA clones revealed the occurrence of differential polyadenylation which gives ERCC-1 transcripts of 3.4 and 3.8 kb in addition to the major 1.1 kb mRNA. Apparent evolutionary conservation of differential polyadenylation of ERCC-1 transcripts suggests a possible role for this mode of RNA processing in the ERCC-1 repair function.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. Gao, D. K. Price, T. Sissung, E. Reed, and W. D. Figg Ethnic disparities in Americans of European descent versus Americans of African descent related to polymorphic ERCC1, ERCC2, XRCC1, and PARP1 Mol. Cancer Ther., May 1, 2008; 7(5): 1246 - 1250. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Druker, T. J. Bruxner, N. J. Lehrbach, and E. Whitelaw Complex patterns of transcription at the insertion site of a retrotransposon in the mouse Nucleic Acids Res., November 1, 2004; 32(19): 5800 - 5808. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Borrmann, R. Schwanbeck, T. Heyduk, B. Seebeck, P. Rogalla, J. Bullerdiek, and J. R. Wisniewski High mobility group A2 protein and its derivatives bind a specific region of the promoter of DNA repair gene ERCC1 and modulate its activity Nucleic Acids Res., December 1, 2003; 31(23): 6841 - 6851. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Chen, J. Wiencke, K. Aldape, A. Kesler-Diaz, R. Miike, K. Kelsey, M. Lee, J. Liu, and M. Wrensch Association of an ERCC1 Polymorphism with Adult-Onset Glioma Cancer Epidemiol. Biomarkers Prev., August 1, 2000; 9(8): 843 - 847. [Abstract] [Full Text] |
||||
![]() |
Q. Li, K. Gardner, L. Zhang, B. Tsang, F. Bostick-Bruton, and E. Reed Cisplatin Induction of ERCC-1 mRNA Expression in A2780/CP70 Human Ovarian Cancer Cells J. Biol. Chem., September 4, 1998; 273(36): 23419 - 23425. [Abstract] [Full Text] [PDF] |
||||



